Roth Capital Downgrades IRadimed Corp (IRMD) to Neutral
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Roth Capital downgraded IRadimed Corp (NASDAQ: IRMD) from Buy to Neutral.
Shares of IRadimed Corp closed at $10.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Cowen Downgrades Under Armour, Inc. (UA) to Market Perform
- FBR Capital Downgrades FuelCell Energy (FCEL) to Market Perform - PT to $5.50
- FBR Capital Downgrades Pandora (P) to Market Perform on Ad Shortfall and Higher Costs
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesRoth Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!